Pfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose
marketwatch.com
news
2022-10-21 13:16:00

Pfizer Inc. PFE, -0.46% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, -3.45% for $110 to $130 per dose once the U.S. market for COVID-19 shots becomes commercial, likely in the first quarter of next year. Pfizer and BioNTech are currently paid $30.50 per vaccine dose by the U.S. government, which contracted with the companies (as well as other vaccine makers like Moderna Inc. MRNA, -4.16% and Novavax Inc. NVAX, -4.18% ) and then made the COVID-19 shots available at no cost to people in the U.
